Ratings and price targets from Nephron Research analysts, and how many of their targets were reached. Latest call 21 July 2025.
| Analyst | Ratings, 12 mo | Targets, 12 mo | Stocks | Avg upside | Reached in 12 mo |
|---|
Analysts with a call in the past 12 months, most active first. Upside and reached are over each analyst's Nephron Research record, shown from 5 targets.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 30 Jul 2025 | PEN | Chris Pasquale | Upgrade | $305 | BUY |
| 21 Jul 2025 | EW | Chris Pasquale | Upgrade | $90 | BUY |
| 6 Mar 2025 | WAT | Jack Meehan | Upgrade | $440 | BUY |
| 3 Dec 2024 | HIMS | Eric Percher | Raised | $30 → $40 | BUY |
| 2 Dec 2024 | ICLR | Jack Meehan | Upgrade | $280 | BUY |
| 2 Dec 2024 | IQV | Jack Meehan | Upgrade | $250 | BUY |
| 29 Aug 2024 | COO | Chris Pasquale | Upgrade | BUY | |
| 28 Aug 2024 | BIO | Jack Meehan | Upgrade | $390 | BUY |
| 30 Jun 2023 | BHG | Joshua Raskin | Upgrade | BUY | |
| 14 Apr 2023 | CTLT | Jack Meehan | Upgrade | BUY | |
| 12 Jul 2022 | PRCT | Chris Pasquale | Target set | $50 | BUY |
| 8 Apr 2020 | UNH | Joshua Raskin | Downgrade | HOLD | |
| 8 Apr 2020 | HUM | Joshua Raskin | Upgrade | BUY |
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
ZelmanVTBTudor PickeringSummit RedstoneSocGen
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.
